Literature DB >> 25974355

Factors that condition the spontaneous reporting of adverse drug reactions among nurses: an integrative review.

Alessia De Angelis1, Sofia Colaceci1, Angela Giusti2, Ercole Vellone1, Rosaria Alvaro1.   

Abstract

AIM: To describe and synthesise previous research on factors conditioning the spontaneous reporting of adverse drug reactions among nurses.
BACKGROUND: Spontaneous reports of adverse drug reactions by health-care providers, are a main instrument for the continuous evaluation of the risk-benefit ratio of every drug. Under-reporting of adverse drug reactions by all health-care providers, in particular by nurses, is a major limitation to this system. EVALUATION: An integrated review of the literature was conducted using MEDLINE, CINAHL, Embase, Scopus databases and Google Scholar. After evaluation for appropriateness related to inclusion/exclusion criteria, 16 studies were included in the final analysis and synthesis. KEY ISSUES: Two factors emerged from the study: (1) intrinsic factors related to nurses' knowledge and attitudes; (2) extrinsic factors related to nurses' interaction with health-care organisations and to the relationship between nurses and physicians. Nurses' attitudes that hinder reporting include ignorance, insecurity, fear and lethargy.
CONCLUSIONS: Nurses are not fully aware of their role in adverse drug reaction reporting. Nurses must acquire greater knowledge to implement specific skills into their daily clinical practice. IMPLICATIONS FOR NURSING MANAGEMENT: To improve nurses' reporting of adverse drug reactions, it is necessary to develop management approaches that modify both intrinsic and extrinsic factors.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  adverse drug reaction reporting systems; attitudes; nurses; pharmacovigilance

Mesh:

Year:  2015        PMID: 25974355     DOI: 10.1111/jonm.12310

Source DB:  PubMed          Journal:  J Nurs Manag        ISSN: 0966-0429            Impact factor:   3.325


  10 in total

Review 1.  The key role of clinical and community health nurses in pharmacovigilance.

Authors:  Caterina Bigi; Guido Bocci
Journal:  Eur J Clin Pharmacol       Date:  2017-08-02       Impact factor: 2.953

2.  Exploring Healthcare Professionals' Practices and Attitudes towards Monitoring and Reporting of Severe Adverse Drug Reactions.

Authors:  Warisara Srisuriyachanchai; Anthony R Cox; Narumol Jarernsiripornkul
Journal:  Healthcare (Basel)       Date:  2022-06-10

3.  Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients.

Authors:  Sieta T de Vries; Petra Denig; Carmen Lasheras Ruiz; François Houÿez; Lisa Wong; Alastair Sutcliffe; Peter G M Mol
Journal:  Drug Saf       Date:  2018-07       Impact factor: 5.606

Review 4.  Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature.

Authors:  Michael Reumerman; J Tichelaar; B Piersma; M C Richir; M A van Agtmael
Journal:  Eur J Clin Pharmacol       Date:  2018-06-20       Impact factor: 2.953

5.  Nurses' Knowledge, Attitudes, and Practice in Relation to Pharmacovigilance and Adverse Drug Reaction Reporting: A Systematic Review.

Authors:  Tahmine Salehi; Naiemeh Seyedfatemi; Mohammad Saeed Mirzaee; Maryam Maleki; Abbas Mardani
Journal:  Biomed Res Int       Date:  2021-04-09       Impact factor: 3.411

6.  A survey of veterinary professionals in Sweden: Adverse event reporting and access to product safety information.

Authors:  James Mount; Karin Sjöström; Veronica Arthurson; Sanna Kreuger
Journal:  Vet Rec Open       Date:  2021-08-05

7.  Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland.

Authors:  J O'Callaghan; B T Griffin; J M Morris; Margaret Bermingham
Journal:  BioDrugs       Date:  2018-06       Impact factor: 5.807

8.  Documentation of antipsychotic-related adverse drug reactions: An educational intervention.

Authors:  Gregory Purcell; Jane McCartney; Shirley-Anne Boschmans
Journal:  S Afr J Psychiatr       Date:  2019-11-27       Impact factor: 1.550

9.  Strengths and Weaknesses of the Pharmacovigilance Systems in Three Arab Countries: A Mixed-Methods Study Using the WHO Pharmacovigilance Indicators.

Authors:  Hamza Garashi; Douglas Steinke; Ellen Schafheutle
Journal:  Int J Environ Res Public Health       Date:  2022-02-22       Impact factor: 3.390

10.  Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK.

Authors:  Sieta T de Vries; Petra Denig; Adriana Andrić; Marina Dimov Di Giusti; Alicia Ptaszynska-Neophytou; Linda Härmark; Peter G M Mol
Journal:  Drug Saf       Date:  2021-08-08       Impact factor: 5.606

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.